Next Article in Journal / Special Issue
What’s Fair Is Fair: Leveling the Playing Field for Young Scientists
Previous Article in Journal / Special Issue
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy
Article Menu

Export Article

Open AccessReview
Vaccines 2018, 6(2), 32; https://doi.org/10.3390/vaccines6020032

Clinical Expectations for Better Influenza Virus Vaccines—Perspectives from the Young Investigators’ Point of View

1
Influenza Centre, Department of Clinical Science, University of Bergen, Bergen 5021, Norway
2
Emergency Care clinic, Haukeland University Hospital, Bergen 5021, Norway
3
K.G. Jebsen Centre for Influenza Vaccine Research, Department of Clinical Science, University of Bergen, Bergen 5021, Norway
*
Author to whom correspondence should be addressed.
Received: 23 March 2018 / Revised: 23 May 2018 / Accepted: 23 May 2018 / Published: 26 May 2018
Full-Text   |   PDF [1280 KB, uploaded 26 May 2018]   |  

Abstract

The influenza virus is one of a few viruses that is capable of rendering an otherwise healthy person acutly bedridden for several days. This impressive knock-out effect, without prodromal symptoms, challenges our immune system. The influenza virus undergoes continuous mutations, escaping our pre-existing immunity and causing epidemics, and its segmented genome is subject to reassortment, resulting in novel viruses with pandemic potential. The personal and socieoeconomic burden from influenza is high. Vaccination is the most cost-effective countermeasure, with several vaccines that are available. The current limitations in vaccine effectivness, combined with the need for yearly updating of vaccine strains, is a driving force for research into developing new and improved influenza vaccines. The lack of public concern about influenza severity, and misleading information concerning vaccine safety contribute to low vaccination coverage even in high-risk groups. The success of future influeza vaccines will depend on an increased public awarness of the disease, and hence, the need for vaccination—aided through improved rapid diagnositics. The vaccines must be safe and broadly acting, with new, measurable correlates of protection and robust post-marketing safety studies, to improve the confidence in influenza vaccines. View Full-Text
Keywords: influenza; human; vaccines; immune response; future; clinical; safety influenza; human; vaccines; immune response; future; clinical; safety
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Mohn, K. .-I.; Zhou, F. Clinical Expectations for Better Influenza Virus Vaccines—Perspectives from the Young Investigators’ Point of View. Vaccines 2018, 6, 32.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top